REFERENCES
- Ford J.L. The Current Status of Solid Dispersions. Pharm. Acta Helv. 1986; 61: 69–88
- Chiou W.L., Riegalman S. Pharmaceutical Applications of Solid Dispersion Systems. J. Pharm. Sci. 1971; 60: 1281–1302
- Serajuddin A.T.M. Solid Dispersions of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems, and Recent Breakthroughs. J. Pharm. Sci. 1999; 88: 1058–1066
- Leuner C., Dressman J. Improving Drug Solubility for Oral Delivery Using Solid Disperions. Eur. J. Pharm. Biopharm. 2000; 50: 47–60
- Gupta M.K., Goldman D., Bogner R.H., Tseng Y. Enhanced Drug Dissolution and Bulk Properties of Solid Dispersions Granulated with a Surface Adsorbent. Pharm. Dev. Technol. 2001; 6: 536–572
- Matsumoto T., Zografi G. Physical Properties of Solid Molecular Dispersions of Indomethacin with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl-acetate) in Relation to Indomethacin Crystallization. Pharm. Res. 1999; 16: 1722–1728
- Pozzi F., Longo A., Lazzarini C., Carenzi A. Formulations of Ubidecarenone with Improved Bioavailability. Eur. J. Pharm. Biopharm. 1991; 37: 243–246
- Sheen P.C., Kim S.I., Petillo J.J., Serajuddin A.T.M. Bioavailability of a Poorly Water-Soluble Drug from Tablet and Solid Dispersion in Humans. J. Pharm. Sci. 1991; 80: 712–714
- Craig D.Q.M. Polyethylene Glycols and Drug Release. Drug Dev. Ind. Pharm. 1990; 16: 2501–2526
- , Price, J. C. Polyethylene Glycol. In Handbook of Pharmaceutical Excipients, 2nd Ed.; Wade, A.; Weller, P. J., Eds. The Pharmaceutical Press: London, 1994; 355–361.
- , Company literature on Neusilin, Fuji Chemical Industry Co. Ltd.: Toyama, Japan, 1997; 3–4.
- , Communications with Dr. Sebastien Branchu, Fuji Chemical Industry Co. Ltd., NJ, 2000.
- Taylor L.S., Zografi G. Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions. Pharm. Res. 1997; 14: 1691–1698
- Hirasawa N., Danjo K., Haruna M., Otsuka A. Physicochemical Characterization and Drug Release Studies of Naproxen Solid Dispersions Using Lactose as a Carrier. Chem. Pharm. Bull. 1998; 46: 1027–1030
- , Silverstein, R.M.; Bassler, G.C.; Morrill, T.C. Spectrometric Identification of Organic Compounds, 5th Ed.; John Wiley and Sons, Inc.: New York, 1991, 91–132.
- Suryanarayanan R. X-ray Power Diffractometry. Drugs Pharm. Sci. 1995; 70: 187–221
- Duclos R., Grenet J., Saiter J.M., Besancon P., Orecchioni A.M. Effect of Ageing on Progesterone-Polyethylene Glycol 6000 Dispersions, X-ray Study. Drug Dev. Ind. Pharm. 1990; 16: 255–265
- , Al-Shammary, F. J.; Mian, N. A.; Mian, M. S. Naproxen. In Analytical Profiles of Drug Substances and Excipients; Brittain, H. G., Ed.; Academic Press Inc.: San Diego, 1992; Vol. 21, 345–372.
- Muramatsu M., Iwahashi M., Takeuchi U. Thermodynamic Relationship Between α and β-Forms of Crystalline Progesterone. J. Pharm. Sci. 1979; 68: 175–177